Literature DB >> 29101110

The Biology of Bone Metastasis.

Mark Esposito1, Theresa Guise2, Yibin Kang1.   

Abstract

Bone metastasis, or the development of secondary tumors within the bone of cancer patients, is a debilitating and incurable disease. Despite its morbidity, the biology of bone metastasis represents one of the most complex and intriguing of all oncogenic processes. This complexity derives from the intricately organized bone microenvironment in which the various stages of hematopoiesis, osteogenesis, and osteolysis are jointly regulated but spatially restricted. Disseminated tumor cells (DTCs) from various common malignancies such as breast, prostate, lung, and kidney cancers or myeloma are uniquely primed to subvert these endogenous bone stromal elements to grow into pathological osteolytic or osteoblastic lesions. This colonization process can be separated into three key steps: seeding, dormancy, and outgrowth. Targeting the processes of dormancy and initial outgrowth offers the most therapeutic promise. Here, we discuss the concepts of the bone metastasis niche, from controlling tumor-cell survival to growth into clinically detectable disease.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29101110      PMCID: PMC5980796          DOI: 10.1101/cshperspect.a031252

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  126 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Red-yellow marrow conversion: its effect on the location of some solitary bone lesions.

Authors:  M E Kricun
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

3.  Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast.

Authors:  Malgorzata Banys; Ines Gruber; Natalia Krawczyk; Sven Becker; Ralph Kurth; Diethelm Wallwiener; Jolanta Jakubowska; Jürgen Hoffmann; Ralf Rothmund; Annette Staebler; Tanja Fehm
Journal:  Breast Cancer Res Treat       Date:  2011-04-01       Impact factor: 4.872

Review 4.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

5.  miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.

Authors:  Sajni Josson; Murali Gururajan; Peizhen Hu; Chen Shao; GinaChia-Yi Chu; Haiyen E Zhau; Chunyan Liu; Kaiqin Lao; Chia-Lun Lu; Yi-Tsung Lu; Jake Lichterman; Srinivas Nandana; Quanlin Li; Andre Rogatko; Dror Berel; Edwin M Posadas; Ladan Fazli; Dhruv Sareen; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

6.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Authors:  D M Anderson; E Maraskovsky; W L Billingsley; W C Dougall; M E Tometsko; E R Roux; M C Teepe; R F DuBose; D Cosman; L Galibert
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

7.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

8.  The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

Authors:  Erming Tian; Fenghuang Zhan; Ronald Walker; Erik Rasmussen; Yupo Ma; Bart Barlogie; John D Shaughnessy
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

9.  Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

Authors:  Oliver Sartor; Robert Coleman; Sten Nilsson; Daniel Heinrich; Svein I Helle; Joe M O'Sullivan; Sophie D Fosså; Aleš Chodacki; Paweł Wiechno; John Logue; Anders Widmark; Dag Clement Johannessen; Peter Hoskin; Nicholas D James; Arne Solberg; Isabel Syndikus; Nicholas J Vogelzang; C Gillies O'Bryan-Tear; Minghua Shan; Øyvind S Bruland; Christopher Parker
Journal:  Lancet Oncol       Date:  2014-05-13       Impact factor: 41.316

10.  Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.

Authors:  Aya Kobayashi; Hiroshi Okuda; Fei Xing; Puspa R Pandey; Misako Watabe; Shigeru Hirota; Sudha K Pai; Wen Liu; Koji Fukuda; Christopher Chambers; Andrew Wilber; Kounosuke Watabe
Journal:  J Exp Med       Date:  2011-11-28       Impact factor: 14.307

View more
  51 in total

Review 1.  Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes.

Authors:  Josiah Ochieng; Gladys Nangami; Amos Sakwe; Cierra Moye; Joel Alvarez; Diva Whalen; Portia Thomas; Philip Lammers
Journal:  Int J Mol Sci       Date:  2018-07-29       Impact factor: 5.923

Review 2.  Bone Metastasis: Find Your Niche and Fit in.

Authors:  Weijie Zhang; Igor Bado; Hai Wang; Hin-Ching Lo; Xiang H-F Zhang
Journal:  Trends Cancer       Date:  2019-01-17

3.  Curcumin Inhibition of TGFβ signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites.

Authors:  Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Julia N Cheng; Paula B Luis; Claus Schneider; Janet L Funk
Journal:  J Nutr Biochem       Date:  2021-08-15       Impact factor: 6.048

4.  Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis.

Authors:  Yi-Hsuan Wu; Zbigniew Gugala; Megan M Barry; Yichao Shen; Subhamoy Dasgupta; Hai Wang
Journal:  Mol Cancer Ther       Date:  2022-08-02       Impact factor: 6.009

Review 5.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

Review 6.  Understanding cachexia in the context of metastatic progression.

Authors:  Anup K Biswas; Swarnali Acharyya
Journal:  Nat Rev Cancer       Date:  2020-03-31       Impact factor: 60.716

7.  The bone microenvironment invigorates metastatic seeds for further dissemination.

Authors:  Weijie Zhang; Igor L Bado; Jingyuan Hu; Ying-Wooi Wan; Ling Wu; Hai Wang; Yang Gao; Hyun-Hwan Jeong; Zhan Xu; Xiaoxin Hao; Bree M Lege; Rami Al-Ouran; Lucian Li; Jiasong Li; Liqun Yu; Swarnima Singh; Hin Ching Lo; Muchun Niu; Jun Liu; Weiyu Jiang; Yi Li; Stephen T C Wong; Chonghui Cheng; Zhandong Liu; Xiang H-F Zhang
Journal:  Cell       Date:  2021-04-19       Impact factor: 41.582

Review 8.  Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics.

Authors:  Bikashita Kalita; Mohane Selvaraj Coumar
Journal:  Cell Oncol (Dordr)       Date:  2021-04-29       Impact factor: 6.730

9.  Cellular plasticity in bone metastasis.

Authors:  Cao Fang; Yibin Kang
Journal:  Bone       Date:  2020-10-15       Impact factor: 4.398

Review 10.  Bone Tropism in Cancer Metastases.

Authors:  Hai Wang; Weijie Zhang; Igor Bado; Xiang H-F Zhang
Journal:  Cold Spring Harb Perspect Med       Date:  2020-10-01       Impact factor: 5.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.